Discover the precision and reliability of the Supreme Peptides IGF-1 LR3 Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “IGF-1 LR3” and contains a premium synthetic peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on cellular growth, anabolic signaling, and tissue development pathways. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a modified analog of naturally occurring IGF-1, engineered for enhanced stability and an extended half-life. It is widely studied in research settings for its role in cell proliferation, differentiation, and anabolic signaling, making it a key compound in studies of growth and tissue development.

Product overview

IGF-1 LR3 is a research-grade peptide consisting of a 83-amino-acid sequence with structural modifications that reduce binding to IGF-binding proteins, increasing its bioavailability and activity in experimental models. Preclinical research associates IGF-1 LR3 with enhanced cellular growth, improved nutrient partitioning, and activation of signaling pathways involved in muscle and tissue development.

Key research features

Cellular growth and proliferation:
IGF-1 LR3 is widely investigated for its ability to stimulate cell growth, division, and differentiation. Research models explore its role in tissue development and regenerative processes.

Anabolic and signaling pathways:
Studies suggest IGF-1 LR3 activates key pathways such as PI3K/Akt and MAPK, supporting research into protein synthesis, nutrient utilization, and cellular adaptation.

Extended activity and bioavailability:
Due to its structural modifications, IGF-1 LR3 demonstrates reduced binding to IGF-binding proteins and prolonged activity, making it valuable for sustained signaling studies in controlled research environments.

IGF-1 LR3 – Suggested Use (Research Context)
Typical Dose: 20–100 mcg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional

Disclaimer:
This product is intended for research purposes only.
Not for human or animal consumption.
No medical claims are made.
Keep out of reach of children.